MUSTANG BIO, INC. Amortization of Debt Issuance Costs and Discounts
MUSTANG BIO, INC. (MBIO) reported Amortization of Debt Issuance Costs and Discounts of $1.80 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2020-11-06
- MUSTANG BIO, INC. amortization of debt issuance costs and discounts for the quarter ending 2020-09-30 was $1.80M, a 500.00% increase year-over-year.
- MUSTANG BIO, INC. amortization of debt issuance costs and discounts for the quarter ending 2020-06-30 was $200.00K, a 0.00% change year-over-year.
- MUSTANG BIO, INC. amortization of debt issuance costs and discounts for the quarter ending 2020-03-31 was $300.00K, a 21328.57% increase year-over-year.
- MUSTANG BIO, INC. amortization of debt issuance costs and discounts for the quarter ending 2019-12-31 was $200.00K.
- MUSTANG BIO, INC. amortization of debt issuance costs and discounts for fiscal 2019 was $700.00K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 3 month as first filed | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 9 month as first filed | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|---|---|
| 2020-09-30 | $1.80M 10-Q · filed 2020-11-06 | $2.00M derived: sum of 2 quarters · filed 2020-11-06 | $2.30M 10-Q · filed 2020-11-06 | $2.50M derived: sum of 4 quarters · filed 2020-11-06 | ||
| 2020-06-30 | $200.00K 10-Q · filed 2020-08-10 | $500.00K 10-Q · filed 2020-08-10 | $700.00K derived: sum of 3 quarters · filed 2020-08-10 | $1.00M derived: sum of 4 quarters · filed 2020-11-06 | ||
| 2020-03-31 | $300.00K 10-Q · filed 2020-05-11 | $500.00K derived: sum of 2 quarters · filed 2020-05-11 | $800.00K derived: sum of 3 quarters · filed 2020-11-06 | $1.00M derived: sum of 4 quarters · filed 2020-11-06 | ||
| 2019-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $500.00K derived: sum of 2 quarters · filed 2020-11-06 | $700.00K derived: sum of 3 quarters · filed 2020-11-06 | $700.00K 10-K · filed 2020-03-16 | ||
| 2019-09-30 | $300.00K 10-Q · filed 2020-11-06 | $500.00K 10-Q · filed 2019-11-12 | $500.00K derived: sum of 2 quarters · filed 2020-11-06 | $500.00K 10-Q · filed 2020-11-06 | $300.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $200.00K 10-Q · filed 2020-08-10 | $200.00K 10-Q · filed 2020-08-10 | ||||
| 2019-03-31 | $1.40K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |